These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26088087)

  • 1. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
    Clinkard D; Barbic D
    CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial.
    Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A
    Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tranexamic acid for the treatment of epistaxis in patients using antiplatelet agents.
    Sanderson M; Powell J; Lang E
    CJEM; 2018 Sep; 20(5):774-776. PubMed ID: 30205859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
    Bridwell RE; April MD; Long B
    Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial.
    Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y
    Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

  • 8. Tranexamic acid in epistaxis: a systematic review.
    Kamhieh Y; Fox H
    Clin Otolaryngol; 2016 Dec; 41(6):771-776. PubMed ID: 26946067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
    Logan JK; Pantle H
    Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
    [No Abstract]   [Full Text] [Related]  

  • 11. Is Tranexamic Acid (TXA) Effective Compared with Anterior Nasal Packing (ANP) in Achieving Cessation of Bleeding in Patients with Anterior Epistaxis?
    Torres E; Johnson MY; Seebald K; Kachhi P
    J Emerg Med; 2022 Jun; 62(6):820-825. PubMed ID: 35545485
    [No Abstract]   [Full Text] [Related]  

  • 12. BET 1: Tranexamic acid in epistaxis: who bloody nose?
    Penrose N; May G
    Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
    Jervis S; Saunders T; Belcher J; Skinner D
    Clin Otolaryngol; 2017 Apr; 42(2):439-442. PubMed ID: 26681525
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis.
    Gottlieb M; DeMott JM; Peksa GD
    Ann Pharmacother; 2019 Jun; 53(6):652-657. PubMed ID: 30577703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate dose of tranexamic acid in the topical treatment of anterior epistaxis, 500 mg vs 1000 mg: A double-blind randomized controlled trial.
    Arikan C; Akyol PY
    Sci Prog; 2024; 107(4):368504241264993. PubMed ID: 39351623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bleeding upper aerodigestive tract tumor-a novel approach with antifibrinolytic agent: case series and literature review.
    Low TH; Huang J; Reid C; Elliott M; Clark JR
    Laryngoscope; 2013 Oct; 123(10):2449-52. PubMed ID: 23553514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis.
    Whitworth K; Johnson J; Wisniewski S; Schrader M
    J Emerg Med; 2020 Feb; 58(2):211-216. PubMed ID: 31899024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Topical Application of Tranexamic Acid in Atraumatic Anterior Epistaxis: A Double-Blind Randomized Clinical Trial.
    Hosseinialhashemi M; Jahangiri R; Faramarzi A; Asmarian N; Sajedianfard S; Kherad M; Soltaniesmaeili A; Babaei A
    Ann Emerg Med; 2022 Sep; 80(3):182-188. PubMed ID: 35752521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.